Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage
Fernando E. García‐Arroyo, Guillermo Gonzaga, Itzel Muñoz-Jiménez, et al.
PLoS ONE (2018) Vol. 13, Iss. 8, pp. e0202901-e0202901
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies
Jing Wang, Yong Chen, Hao Zhong, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 14, pp. 3979-3989
Closed Access | Times Cited: 210
Uric Acid and Hypertension: An Update With Recommendations
Laura Gabriela Sánchez‐Lozada, Bernardo Rodríguez‐Iturbe, Eric E. Kelley, et al.
American Journal of Hypertension (2020) Vol. 33, Iss. 7, pp. 583-594
Open Access | Times Cited: 161
Limosilactobacillus fermentum JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid
Ying Wu, Ze Ye, Pengya Feng, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 137
The Role of the Intestine in the Development of Hyperuricemia
Hui Yin, Na Liu, Jie Chen
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 93
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Zhilei Wang, Yuchen Li, Wenhao Liao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 90
The potential of probiotics in the amelioration of hyperuricemia
Hongyuan Zhao, Zhaoxin Lu, Yingjian Lu
Food & Function (2022) Vol. 13, Iss. 5, pp. 2394-2414
Closed Access | Times Cited: 74
Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review
Stefanos Roumeliotis, Athanasios Roumeliotis, Evangelia Dounousi, et al.
Nutrients (2019) Vol. 11, Iss. 8, pp. 1911-1911
Open Access | Times Cited: 119
Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis
Natalia L. Rukavina Mikusic, Nicolás Martín Kouyoumdzian, Marcelo R. Choi
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 3, pp. 303-320
Open Access | Times Cited: 114
Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats
Laura Gabriela Sánchez‐Lozada, Ana Andres‐Hernando, Fernando E. García‐Arroyo, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 11, pp. 4272-4281
Open Access | Times Cited: 107
The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia
Xiu Liu, Qiulan Lv, Hongyan Ren, et al.
PeerJ (2020) Vol. 8, pp. e8664-e8664
Open Access | Times Cited: 83
Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage
A. Ahsan Ejaz, Takahiko Nakagawa, Mehmet Kanbay, et al.
Seminars in Nephrology (2020) Vol. 40, Iss. 6, pp. 574-585
Open Access | Times Cited: 78
Probiotics, Prebiotics and Synbiotics—A Promising Strategy in Prevention and Treatment of Cardiovascular Diseases?
Beata Olas
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9737-9737
Open Access | Times Cited: 73
Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats
Yi‐Wei Kuo, Shih‐Hung Hsieh, Jui‐Fen Chen, et al.
PeerJ (2021) Vol. 9, pp. e11209-e11209
Open Access | Times Cited: 58
Gut Dysbiosis and Kidney Diseases
Chujin Cao, Han Zhu, Ying Yao, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 44
A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects
Rym Ben Othman, N. Ben Amor, F. Mahjoub, et al.
Endocrinology Diabetes & Metabolism (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 33
Exploring the mechanism underlying hyperuricemia using comprehensive research on multi-omics
Hengrui Liu, Ruolin Xie, Qiongqiong Dai, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Hyperuricemia is associated with impaired intestinal permeability in mice
Daxing Xu, Qiulan Lv, Xiaofeng Wang, et al.
AJP Gastrointestinal and Liver Physiology (2019) Vol. 317, Iss. 4, pp. G484-G492
Open Access | Times Cited: 75
<p>Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications</p>
Min Gong, Song Wen, Thiquynhnga Nguyen, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 943-962
Open Access | Times Cited: 66
Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
Tadej Petreski, Robert Ekart, Radovan Hojs, et al.
Renal Failure (2020) Vol. 42, Iss. 1, pp. 978-986
Open Access | Times Cited: 56
Impact of Camellia japonica Bee Pollen Polyphenols on Hyperuricemia and Gut Microbiota in Potassium Oxonate-Induced Mice
Yuanyuan Xu, Xirong Cao, Haoan Zhao, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2665-2665
Open Access | Times Cited: 56
Biomineralization Induced by Cells of Sporosarcina pasteurii: Mechanisms, Applications and Challenges
Yang Wu, Huimin Li, Yang Li
Microorganisms (2021) Vol. 9, Iss. 11, pp. 2396-2396
Open Access | Times Cited: 49
Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation
Qian Ren, Lu Cheng, Fan Guo, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 37, pp. 10932-10942
Closed Access | Times Cited: 43
The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
Xinghong Wu, Chongge You
PeerJ (2022) Vol. 11, pp. e14554-e14554
Open Access | Times Cited: 36
Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development
Hye Won Kim, Eun-Jeong Yoon, Seok Hoon Jeong, et al.
Yonsei Medical Journal (2022) Vol. 63, Iss. 3, pp. 241-241
Open Access | Times Cited: 31
The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment
Shuting Tong, Peiyu Zhang, Qi Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top